#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Small cell lung cancer recurrent Palmoplantar pustulosis Philadelphia chromosome positive Round cell liposarcoma Acute hepatic failure Follicle centre lymphoma follicular grade I II – III refractory Craniocerebral injury Becker's muscular dystrophy Solitary fibrous tumour Cutaneous calcification Hereditary hypophosphataemic rickets Erythema multiforme Epidermolysis bullosa Systemic sclerosis pulmonary More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Trials in Disease Small intestine leiomyosarcoma – Trials in Disease Indolent systemic mastocytosis – Trials in Disease Pleural mesothelioma malignant – Trials in Disease Malignant fibrous histiocytoma – Trials in Disease Mucous membrane pemphigoid – Basic Information Osteosarcoma – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Treatment X-linked lymphoproliferative syndrome Fabry’s disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Festuca Elatior Pollen Extract Glatiramer Acetate Iomeprol Sodium Citrate Vinblastine Sulfate ZILUCOPLAN Mebeverine Hydrochloride Azd3427 Cefoxitin Sodium MAPLIRPACEPT Dapagliflozin Propanediol Cusatuzumab Ibrutinib Cimetidine Hydrochloride Haloperidol Decanoate SPY002 Oxitriptan Ascorbic Acid Arachis Hypogaea Flour Sulfur Hexafluoride More therapies…

    Learn about Your Condition

    Diphtheria Neutropenia Migraine without aura Neonatal respiratory failure Pneumonia chlamydial Osteonecrosis of jaw Biopsy heart Adrenocortical carcinoma Carotid artery stenosis Perthes disease Hypoaesthesia Autoimmune disorder Pancreatic neoplasm Neuroblastoma recurrent Sickle cell anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness and Safety of CR9114 for Preventing Influenza in Healthy Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • WILD-TYPE A INFLUENZA VIRUS A/BELGIUM/4217/2015 (H3N2)
    Belgium

  • Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Vosoritide
    Germany Spain

  • Study on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypoparathyroidism
    Investigated Drugs:
    • Alfacalcidol
    • Calcitriol
    • Calcium Carbonate
    Belgium Denmark France Germany Hungary Italy +4

  • Efficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial

    Not recruiting

    4 1
    Investigated Drugs:
    • Tulisokibart
    France Germany Italy The Netherlands Spain

  • A study to test if tibulizumab works and is safe for adults with systemic sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Hungary Poland Romania Spain

  • A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Overweight
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Germany Hungary Ireland Poland
Previous Page
1 … 1,681 1,682 1,683 1,684 1,685 … 1,695
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!